364 related articles for article (PubMed ID: 36849062)
1. Glutamine metabolism in breast cancer and possible therapeutic targets.
Li S; Zeng H; Fan J; Wang F; Xu C; Li Y; Tu J; Nephew KP; Long X
Biochem Pharmacol; 2023 Apr; 210():115464. PubMed ID: 36849062
[TBL] [Abstract][Full Text] [Related]
2. The pathways related to glutamine metabolism, glutamine inhibitors and their implication for improving the efficiency of chemotherapy in triple-negative breast cancer.
Delgir S; Bastami M; Ilkhani K; Safi A; Seif F; Alivand MR
Mutat Res Rev Mutat Res; 2021; 787():108366. PubMed ID: 34083056
[TBL] [Abstract][Full Text] [Related]
3. Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis.
DeBerardinis RJ; Mancuso A; Daikhin E; Nissim I; Yudkoff M; Wehrli S; Thompson CB
Proc Natl Acad Sci U S A; 2007 Dec; 104(49):19345-50. PubMed ID: 18032601
[TBL] [Abstract][Full Text] [Related]
4. Glutamine to proline conversion is associated with response to glutaminase inhibition in breast cancer.
Grinde MT; Hilmarsdottir B; Tunset HM; Henriksen IM; Kim J; Haugen MH; Rye MB; Mælandsmo GM; Moestue SA
Breast Cancer Res; 2019 May; 21(1):61. PubMed ID: 31088535
[TBL] [Abstract][Full Text] [Related]
5. Dual inhibition of glutaminase and carnitine palmitoyltransferase decreases growth and migration of glutaminase inhibition-resistant triple-negative breast cancer cells.
Reis LMD; Adamoski D; Ornitz Oliveira Souza R; Rodrigues Ascenção CF; Sousa de Oliveira KR; Corrêa-da-Silva F; Malta de Sá Patroni F; Meira Dias M; Consonni SR; Mendes de Moraes-Vieira PM; Silber AM; Dias SMG
J Biol Chem; 2019 Jun; 294(24):9342-9357. PubMed ID: 31040181
[TBL] [Abstract][Full Text] [Related]
6. A Critical Role of Glutamine and Asparagine γ-Nitrogen in Nucleotide Biosynthesis in Cancer Cells Hijacked by an Oncogenic Virus.
Zhu Y; Li T; Ramos da Silva S; Lee JJ; Lu C; Eoh H; Jung JU; Gao SJ
mBio; 2017 Aug; 8(4):. PubMed ID: 28811348
[TBL] [Abstract][Full Text] [Related]
7. High extracellular lactate causes reductive carboxylation in breast tissue cell lines grown under normoxic conditions.
Brodsky AN; Odenwelder DC; Harcum SW
PLoS One; 2019; 14(6):e0213419. PubMed ID: 31181081
[TBL] [Abstract][Full Text] [Related]
8. Benzylserine inhibits breast cancer cell growth by disrupting intracellular amino acid homeostasis and triggering amino acid response pathways.
van Geldermalsen M; Quek LE; Turner N; Freidman N; Pang A; Guan YF; Krycer JR; Ryan R; Wang Q; Holst J
BMC Cancer; 2018 Jun; 18(1):689. PubMed ID: 29940911
[TBL] [Abstract][Full Text] [Related]
9. Glutaminase is essential for the growth of triple-negative breast cancer cells with a deregulated glutamine metabolism pathway and its suppression synergizes with mTOR inhibition.
Lampa M; Arlt H; He T; Ospina B; Reeves J; Zhang B; Murtie J; Deng G; Barberis C; Hoffmann D; Cheng H; Pollard J; Winter C; Richon V; Garcia-Escheverria C; Adrian F; Wiederschain D; Srinivasan L
PLoS One; 2017; 12(9):e0185092. PubMed ID: 28950000
[TBL] [Abstract][Full Text] [Related]
10. Multi-scale computational study of the Warburg effect, reverse Warburg effect and glutamine addiction in solid tumors.
Shan M; Dai D; Vudem A; Varner JD; Stroock AD
PLoS Comput Biol; 2018 Dec; 14(12):e1006584. PubMed ID: 30532226
[TBL] [Abstract][Full Text] [Related]
11. Glutamine Is Required for M1-like Polarization of Macrophages in Response to Mycobacterium tuberculosis Infection.
Jiang Q; Qiu Y; Kurland IJ; Drlica K; Subbian S; Tyagi S; Shi L
mBio; 2022 Aug; 13(4):e0127422. PubMed ID: 35762591
[TBL] [Abstract][Full Text] [Related]
12. Pyruvate anaplerosis is a mechanism of resistance to pharmacological glutaminase inhibition in triple-receptor negative breast cancer.
Singleton DC; Dechaume AL; Murray PM; Katt WP; Baguley BC; Leung EY
BMC Cancer; 2020 May; 20(1):470. PubMed ID: 32450839
[TBL] [Abstract][Full Text] [Related]
13. Bone metastatic breast cancer cells display downregulation of PKC-ζ with enhanced glutamine metabolism.
Tandon M; Othman AH; Winogradzki M; Pratap J
Gene; 2021 Apr; 775():145419. PubMed ID: 33444686
[TBL] [Abstract][Full Text] [Related]
14. Estradiol stimulates the biosynthetic pathways of breast cancer cells: detection by metabolic flux analysis.
Forbes NS; Meadows AL; Clark DS; Blanch HW
Metab Eng; 2006 Nov; 8(6):639-52. PubMed ID: 16904360
[TBL] [Abstract][Full Text] [Related]
15. Targeting glutamine metabolism as a therapeutic strategy for cancer.
Jin J; Byun JK; Choi YK; Park KG
Exp Mol Med; 2023 Apr; 55(4):706-715. PubMed ID: 37009798
[TBL] [Abstract][Full Text] [Related]
16. Amino Acid Transporters and Glutamine Metabolism in Breast Cancer.
Cha YJ; Kim ES; Koo JS
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29562706
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Glucose Transporters and Glutaminase Synergistically Impairs Tumor Cell Growth.
Reckzeh ES; Karageorgis G; Schwalfenberg M; Ceballos J; Nowacki J; Stroet MCM; Binici A; Knauer L; Brand S; Choidas A; Strohmann C; Ziegler S; Waldmann H
Cell Chem Biol; 2019 Sep; 26(9):1214-1228.e25. PubMed ID: 31303578
[TBL] [Abstract][Full Text] [Related]
18. IL4 receptor α mediates enhanced glucose and glutamine metabolism to support breast cancer growth.
Venmar KT; Kimmel DW; Cliffel DE; Fingleton B
Biochim Biophys Acta; 2015 May; 1853(5):1219-28. PubMed ID: 25746764
[TBL] [Abstract][Full Text] [Related]
19. The glutaminase inhibitor telaglenastat enhances the antitumor activity of signal transduction inhibitors everolimus and cabozantinib in models of renal cell carcinoma.
Emberley E; Pan A; Chen J; Dang R; Gross M; Huang T; Li W; MacKinnon A; Singh D; Sotirovska N; Steggerda SM; Wang T; Parlati F
PLoS One; 2021; 16(11):e0259241. PubMed ID: 34731180
[TBL] [Abstract][Full Text] [Related]
20. A metabolic core model elucidates how enhanced utilization of glucose and glutamine, with enhanced glutamine-dependent lactate production, promotes cancer cell growth: The WarburQ effect.
Damiani C; Colombo R; Gaglio D; Mastroianni F; Pescini D; Westerhoff HV; Mauri G; Vanoni M; Alberghina L
PLoS Comput Biol; 2017 Sep; 13(9):e1005758. PubMed ID: 28957320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
